Grifols Diagnostic Solutions INC.
Doing business as Grifols Diagnostic Solutions INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersEmeryville, CA
US patents4
SAM.gov UEIR4N2Y6E9D6H7
CAGE code7AJ96
Incorporated inDE
- medicines
- healthcare
- hospitals
- therapeutic areas
- 110 countries
Named on the company’s own website, read JUL 29, 2026
What they make
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2021–2024, 4 of them in the five years to SEP 2025.
Measurement 3Biotechnology 1
- Immunoassays and engineered proteins for monitoring antibody treatments to the immune checkpoint inhibitors PD1 and PD-L1US 11,919,938 · granted MAR 5, 2024
- Compositions, methods and/or kits comprising a recombinant human CD38- extracellular domainUS 11,708,418 · granted JUL 25, 2023
- Method to homogenize parvovirus B19 in clinical samplesUS 11,242,571 · granted FEB 8, 2022
- Device and method for detecting blood group antigens by means of an incomplete antibodyUS 11,169,160 · granted NOV 9, 2021
Granted to Grifols Diagnostic Solutions INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plants
3 FACILITIES| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Grifols Diagnostic Solutions INC. | Emeryville | CA | — | ACTIVE |
| Grifols Diagnostic Solutions INC O Bldg | Emeryville | CA | — | UNVERIFIED |
| Grifols Diagnostic Solutions, INC. | San Diego | CA | — | UNVERIFIED |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.